Style | Citing Format |
---|---|
MLA | Ananloo ES, Yoosefee S, Karimipour M. "Neuregulin1 Gene Variants As a Biomarker for Cognitive Impairments in Patients With Schizophrenia." European Journal of Psychiatry, vol. 34, no. 1, 2020, pp. 11-19. |
APA | Ananloo ES, Yoosefee S, Karimipour M (2020). Neuregulin1 Gene Variants As a Biomarker for Cognitive Impairments in Patients With Schizophrenia. European Journal of Psychiatry, 34(1), 11-19. |
Chicago | Ananloo ES, Yoosefee S, Karimipour M. "Neuregulin1 Gene Variants As a Biomarker for Cognitive Impairments in Patients With Schizophrenia." European Journal of Psychiatry 34, no. 1 (2020): 11-19. |
Harvard | Ananloo ES, Yoosefee S, Karimipour M (2020) 'Neuregulin1 Gene Variants As a Biomarker for Cognitive Impairments in Patients With Schizophrenia', European Journal of Psychiatry, 34(1), pp. 11-19. |
Vancouver | Ananloo ES, Yoosefee S, Karimipour M. Neuregulin1 Gene Variants As a Biomarker for Cognitive Impairments in Patients With Schizophrenia. European Journal of Psychiatry. 2020;34(1):11-19. |
BibTex | @article{ author = {Ananloo ES and Yoosefee S and Karimipour M}, title = {Neuregulin1 Gene Variants As a Biomarker for Cognitive Impairments in Patients With Schizophrenia}, journal = {European Journal of Psychiatry}, volume = {34}, number = {1}, pages = {11-19}, year = {2020} } |
RIS | TY - JOUR AU - Ananloo ES AU - Yoosefee S AU - Karimipour M TI - Neuregulin1 Gene Variants As a Biomarker for Cognitive Impairments in Patients With Schizophrenia JO - European Journal of Psychiatry VL - 34 IS - 1 SP - 11 EP - 19 PY - 2020 ER - |